Korea's First ENT Specialty Hospital — Ministry-Designated Excellence in Seoul
4.9 Patient Satisfaction
en-US
· Needs Clinic Confirmation
Lifestyle & Metabolic Diseases
Lifestyle and metabolic diseases — including hypertension, type 2 diabetes, dyslipidemia, obesity, and metabolic syndrome .
Schedule a ConsultationWhat Are Lifestyle and Metabolic Diseases? Understanding Chronic Conditions That Require Long-Term Management
Lifestyle and metabolic diseases — including hypertension, type 2 diabetes, dyslipidemia, obesity, and metabolic syndrome — are among the most prevalent chronic health conditions affecting adults globally. They share common underlying drivers: sedentary lifestyle, dietary excess, weight gain, and genetic predisposition — and they cluster together in individuals, multiplying cardiovascular and organ damage risk when present in combination.
These conditions are called lifestyle diseases not because they are solely caused by lifestyle choices — genetics and biology play significant roles — but because lifestyle modification is both a primary prevention strategy and an essential component of their management alongside medication. Blood pressure that is brought under control through a combination of appropriate medication and sustained dietary and activity changes delivers better long-term outcomes than medication alone. Blood glucose managed with metformin and meaningful dietary change reduces the risk of diabetic complications more effectively than pharmacology in isolation.
The chronic nature of these conditions — requiring years or decades of consistent management — demands a specialist who provides not just diagnosis and initial prescription, but structured long-term monitoring, proactive adjustment of management as the clinical picture evolves, and sustained support for the lifestyle changes that underpin good metabolic health. At HANA ENT Hospital, lifestyle and metabolic disease management is provided by a dedicated internal medicine specialist within the hospital's integrated Internal Medicine department.
Who Needs Lifestyle and Metabolic Disease Assessment?
Specialist internal medicine evaluation is recommended for any adult with established or suspected metabolic conditions. Seek assessment if you:
- Have been told your blood pressure is elevated and have not started or reviewed treatment
- Have been diagnosed with hypertension and are not achieving target blood pressure control
- Have elevated fasting blood glucose, HbA1c, or have been told you have pre-diabetes or type 2 diabetes
- Have abnormal lipid results — high LDL cholesterol, low HDL, or elevated triglycerides — not yet managed
- Have metabolic syndrome — the combination of central obesity, elevated blood pressure, abnormal blood glucose, and dyslipidemia
- Are overweight or obese with weight-related health complications requiring medical management alongside lifestyle intervention
- Have a family history of cardiovascular disease, diabetes, or stroke and want proactive metabolic risk assessment
- Have known thyroid dysfunction — hypothyroidism or hyperthyroidism — requiring medication management and monitoring
- Have non-alcoholic fatty liver disease identified on imaging, requiring monitoring and metabolic management
- Are managing one or more chronic metabolic conditions and seeking a specialist for structured long-term follow-up
[Schedule Your Metabolic Health Evaluation Today]
Meet the Lifestyle and Metabolic Disease Specialist at HANA ENT Hospital
Dr. YoungMi LeeInternal Medicine
Dr. YoungMi Lee — Internal Medicine Resident & Fellow, Department of Gastroenterology, Asan Medical Center · Lifetime Member, Korean Society of Gastroenterology & Korean Society of Gastrointestinal Endoscopy.
Dr. YoungMi Lee leads HANA ENT Hospital's Internal Medicine department — providing adult medical care across digestive health, lifestyle disease management, and preventive medicine. Her residency and fellowship training at Asan Medical Center — one of Korea's largest and most respected academic medical institutions — provide the internal medicine depth and clinical breadth that comprehensive metabolic disease management requires. Her lifetime membership in the Korean Society of Gastroenterology and Korean Society of Gastrointestinal Endoscopy reflects sustained professional engagement with adult internal medicine across its full range.
Her clinical approach to lifestyle and metabolic disease management is individualized — recognizing that blood pressure targets, glucose management intensity, and lifestyle modification strategies must be tailored to each patient's age, co-existing conditions, medication tolerance, and personal circumstances. Metabolic conditions interact with each other and with ENT conditions managed elsewhere in the hospital — OSA worsens hypertension and glucose control; hypothyroidism affects cardiovascular risk and cognitive function — and Dr. Lee's internal medicine oversight within HANA ENT Hospital's integrated system enables these interactions to be managed holistically.
Lifestyle and Metabolic Conditions Managed
- Hypertension (high blood pressure) — Hypertension is defined as consistently elevated blood pressure — generally 130/80 mmHg or above by current guidelines — and is a major modifiable risk factor for stroke, coronary artery disease, heart failure, and kidney disease. It is largely asymptomatic until complications occur — reinforcing the importance of regular blood pressure monitoring and proactive management. Treatment at HANA ENT Hospital combines lifestyle modification — dietary sodium reduction, weight management, physical activity — with individualized antihypertensive medication where indicated. Blood pressure target and medication selection are individualized based on age, co-existing conditions (diabetes, kidney disease, cardiovascular risk), and patient factors. Regular follow-up monitors blood pressure control and adjusts management as needed. OSA — a recognized secondary cause of hypertension managed within HANA ENT Hospital's Sleep Center — is assessed concurrently where clinically indicated.
- Type 2 diabetes and pre-diabetes — Type 2 diabetes is a chronic metabolic condition characterized by insulin resistance and progressive beta-cell dysfunction — resulting in elevated blood glucose that, if inadequately controlled, causes microvascular damage to the kidneys, eyes, and nerves, and significantly increases macrovascular cardiovascular risk. Pre-diabetes — impaired fasting glucose or impaired glucose tolerance — is a critical intervention point where lifestyle modification can prevent or delay progression to type 2 diabetes in many patients. At HANA ENT Hospital, diabetes management is individualized — combining evidence-based glucose-lowering medication (metformin and beyond, selected based on individual risk profile and tolerability) with structured dietary and physical activity guidance. HbA1c, renal function, and cardiovascular risk factors are monitored regularly. Individual glucose targets are set based on age, duration of diabetes, and co-existing conditions.
- Dyslipidemia — Abnormal blood lipid levels — elevated LDL cholesterol, low HDL, or elevated triglycerides — are major modifiable cardiovascular risk factors. Management is individualized based on the overall cardiovascular risk profile rather than lipid levels in isolation: a patient with diabetes and hypertension requires more aggressive LDL reduction than one with isolated mild dyslipidemia and no other risk factors. Treatment combines dietary modification — reduced saturated fat, increased fiber — with statin or other lipid-lowering therapy where indicated. Lipid levels and liver function are monitored at regular follow-up intervals. Triglyceride management also incorporates alcohol reduction and carbohydrate modification where relevant.
- Metabolic syndrome and obesity — Metabolic syndrome — the combination of central obesity, elevated blood pressure, impaired glucose metabolism, and dyslipidemia — significantly multiplies cardiovascular and type 2 diabetes risk beyond the sum of its individual components. Management requires simultaneous attention to each component alongside weight management as the primary modifiable driver. At HANA ENT Hospital, metabolic syndrome management combines structured lifestyle modification guidance — caloric balance, dietary quality, physical activity targets — with individualized medical management of each metabolic component. Realistic, sustainable weight management goals are set collaboratively — acknowledging that meaningful benefit is achievable with modest weight loss (5–10% of body weight) maintained consistently.
- Thyroid conditions — Hypothyroidism — underactive thyroid — causes fatigue, weight gain, cold intolerance, and cognitive slowing, and increases cardiovascular risk if undertreated. Hyperthyroidism — overactive thyroid — causes weight loss, palpitations, heat intolerance, and anxiety. Both conditions are managed with medication adjusted to normalize thyroid hormone levels — thyroid stimulating hormone (TSH) monitoring at regular intervals guides medication titration. Thyroid conditions interact with cardiovascular risk, lipid metabolism, and cognitive function — making internal medicine oversight of thyroid management particularly relevant in the context of HANA ENT Hospital's integrated neurological and metabolic care.
Lifestyle and Metabolic Disease Management Process
1. Clinical Consultation & Medical History: Detailed medical history covering current symptoms, known diagnoses, family history, current medications, dietary habits, physical activity level, smoking, and alcohol use. Blood pressure measurement.
2. Metabolic Risk Assessment Blood Tests: Fasting glucose and HbA1c, lipid profile (total cholesterol, LDL, HDL, triglycerides), thyroid function (TSH, free T4), liver function, kidney function, and full blood count — providing a comprehensive metabolic and organ function baseline.
3. Cardiovascular Risk Calculation: Ten-year cardiovascular risk assessment using validated risk calculators — integrating age, blood pressure, lipid levels, smoking status, and diabetes — providing a framework for treatment intensity decisions.
4. Individualized Management Plan: Medication management and lifestyle modification recommendations individualized to each patient's risk profile, co-existing conditions, and personal circumstances. Treatment targets set realistically and collaboratively — ensuring patients understand what management aims to achieve and why.
5. Lifestyle Modification Guidance: Practical, actionable dietary and physical activity guidance — evidence-based but adapted to each patient's baseline habits and circumstances. Weight management support integrated where relevant. Smoking cessation support provided where indicated.
6. Structured Long-Term Monitoring: Regular follow-up with repeat blood tests, blood pressure monitoring, and medication review at appropriate intervals. Management adjusted based on evolving clinical findings. Long-term metabolic and cardiovascular risk reduction is the overarching goal of every management plan.
Metabolic Disease Management Results, Safety, and Realistic Expectations
Lifestyle and metabolic disease management produces the most meaningful long-term outcomes when medication and lifestyle change are sustained consistently over years — not weeks. Blood pressure control achievable with appropriate medication and lifestyle modification meaningfully reduces stroke and heart attack risk. HbA1c reduction with diabetes management reduces the risk of diabetic complications proportionally. Lipid management with statins reduces cardiovascular event risk substantially in high-risk patients.
Patients should approach metabolic disease management with realistic long-term expectations: these are chronic conditions requiring ongoing management — not acute problems resolved with a single treatment course. The role of HANA ENT Hospital's internal medicine specialist is not simply to prescribe — it is to provide the structured monitoring, proactive adjustment, and sustained clinical support that long-term metabolic risk reduction requires.
Why Choose HANA ENT Hospital for Lifestyle and Metabolic Disease Management?
HANA ENT Hospital is Korea's first and Seoul's only ENT specialist hospital officially designated by the Ministry of Health and Welfare — independently verified standards renewed consecutively since 1995. The Internal Medicine department — led by Dr. YoungMi Lee, trained at Asan Medical Center — provides adult metabolic disease management within an integrated specialist hospital environment that also manages sleep disorders, neurological conditions, and ENT conditions that intersect with metabolic health.
The integration of Internal Medicine, Sleep Center, and Neurology within the same institution is particularly relevant for metabolic disease patients — OSA worsening hypertension and glucose control can be managed concurrently within the same specialist system. With over 3.15 million outpatient visits and a one-stop clinical system, HANA ENT Hospital provides metabolic disease management with the convenience and integrated oversight that long-term chronic disease care requires.
Key reasons to choose HANA ENT Hospital for metabolic disease management:
- Internal medicine specialist — Asan Medical Center trained — comprehensive metabolic risk assessment and individualized long-term management
- Integrated Internal Medicine + Sleep + Neurology — OSA, stroke risk, and cognitive factors managed alongside metabolic conditions within the same system
- One-stop convenience — metabolic health management alongside ENT and sleep care within the same specialist hospital
- Seoul's only Ministry-designated ENT specialist hospital — accredited specialist care, renewed consecutively since 1995
Patient Experiences: Metabolic Disease Management at HANA ENT Hospital
Hypertension and Metabolic Syndrome Patient, 50s
A patient in their mid-50s attending HANA ENT Hospital for sleep apnea management was referred internally for metabolic assessment. Blood tests confirmed elevated LDL, impaired fasting glucose, and blood pressure above target. A comprehensive metabolic management plan was developed — antihypertensive medication initiated, statin therapy started, and dietary modification guidance provided. CPAP therapy for OSA was continued concurrently. At six-month follow-up, blood pressure and lipid levels were within target range and HbA1c had improved from the pre-diabetes range.
Type 2 Diabetes Patient, 60s
A patient in their early 60s presented with newly diagnosed type 2 diabetes identified on routine blood testing — HbA1c 8.2%. Internal medicine consultation established the diagnosis, assessed for early complications, and initiated metformin alongside individualized dietary guidance. Regular follow-up over twelve months documented progressive HbA1c improvement to 6.8% — with the patient reporting sustained dietary changes and increased physical activity as central components of their management.
Take Control of Your Metabolic Health — Before Complications Develop
Hypertension, diabetes, dyslipidemia, and metabolic syndrome are manageable conditions — but managing them effectively requires specialist oversight, structured monitoring, and sustained effort over the long term. At HANA ENT Hospital — The First ENT Specialty Hospital in Korea, The Only ENT Specialty Hospital in Seoul — Dr. YoungMi Lee provides expert internal medicine metabolic assessment and individualized long-term management within an integrated specialist care system.
Book your consultation today. Metabolic risk assessment, blood tests, and individualized management planning — all within a single specialist visit.
[Book Your Metabolic Health Consultation at HANA ENT Hospital]
For appointment scheduling and international patient inquiries, contact our patient services desk directly.
Other Services
Explore additional treatments offered by our specialists.
Voice Disorders
The human voice is produced by the precise vibration of the vocal cords — two small but remarkably complex structures housed within the larynx.
Learn More
Respiratory Conditions
Respiratory conditions encompass a broad range of diseases affecting the lungs, bronchi, and airways.
Learn More
Cognitive Decline & Early Dementia
Cognitive decline refers to measurable reduction in memory, attention, language, executive function, or visuospatial ability.
Learn More
